Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-31
- Last Posted Date
- 2010-08-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1175
- Registration Number
- NCT00394277
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-23
- Last Posted Date
- 2015-08-28
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 424
- Registration Number
- NCT00391092
A Study of Aleglitazar in Patients With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 332
- Registration Number
- NCT00388518
A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-10-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 18
- Registration Number
- NCT00388986
A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 107
- Registration Number
- NCT00377182
A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2015-12-31
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 31
- Registration Number
- NCT00377741
A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 33
- Registration Number
- NCT00377442
COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 48
- Registration Number
- NCT00377481
A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2011-12-06
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 370
- Registration Number
- NCT00377637
A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 356
- Registration Number
- NCT00377234
© Copyright 2024. All Rights Reserved by MedPath